Skip to content

Clinical trials

Phase 2 Myasthenia Gravis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myasthenia Gravis Phase: Phase 2 Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20091
20101
20143
20154
20161
20172
20194
20204
20223
20231
20243
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting7
Terminated6
Active, not recruiting3
Not yet recruiting2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.3
argenx3
Grifols Therapeutics LLC2
Momenta Pharmaceuticals, Inc.2
Tang-Du Hospital2
American University of Beirut Medical Center1
Amgen1
Assistance Publique - Hôpitaux de Paris1
Cartesian Therapeutics1
Charite University, Berlin, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myasthenia Gravis36
Arthritis, Rheumatoid1
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1
Lambert-Eaton Myasthenic Syndrome1
Lupus Erythematosus, Systemic1
Myositis1
Neuromyelitis Optica1
Opsoclonus-Myoclonus Syndrome1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating1

Trials

Showing 76 to 36 of 36. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.